Cholestyramine
Cholestyramine is a pharmaceutical drug with 19 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
15 of 15 finished
0.0%
0 ended early
4
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
Clinical Trials (19)
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
Post Coronary Artery Bypass Graft (CABG) Study
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
Harvard Atherosclerosis Reversibility Project (HARP)
Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
NHLBI Type II Coronary Intervention Study
Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale
Low Doses of Cholestyramine in the Treatment of Hyperthyroidism
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19